"there may be subtle differences (between animals and humans) that we don't know about," klein said.
.
county grand jury report finds shortcomings in hepatitis response
. the software identified and measured a marker of svd and then gave a score indicating how severe the disease was ranging from mild to severe.
.
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.
.